Vital Signs Monitoring Devices Market 2025: Welch Allyn (a subsidiary of Hill-Rom Holdings, Inc.), Nonin Medical Inc., Masimo Corporation, SunTech Medical, Inc. (a subsidiary of Halma plc)

Industry Trend Analysis
The global vital signs monitoring devices market is expected to be around 6 billion by 2025. These devices monitor vital parameters such as heart rate, blood pressure, body temperature and respiratory rate. Vital signs monitoring devices record and provide useful data related to patients’ vital parameters to be used to assess their health status. The market is largely driven by factors such as rising inclination towards home healthcare, increase in geriatric population, and rise in incidence of chronic disorders. Chronic conditions such as high blood pressure can lead to severe consequences such as stroke and heart diseases. According to the June 2016 report by the Centers for Disease Control and Prevention (CDC), nearly 75 million adults in America have high blood pressure, whereas, only half of these people have their condition under control. Such high prevalence of blood pressure will in turn fuel the demand for blood pressure monitoring devices thereby contributing to the market growth. Furthermore, favorable reimbursement scenario for monitoring devices, especially in developed countries is also contributing to the market growth. However, lack of awareness about vital signs monitoring devices in emerging countries can hinder the market growth in coming few years.

Product Outlook and Trend Analysis
Blood pressure monitoring devices segment accounted for the major share of the global vital signs monitoring devices market in 2016 owing to a rise in incidence of chronic diseases such as diabetes, hypertension and other lifestyle related disorders. Pulse oximeters segment is expected to exhibit fastest growth during the forecast period owing to an increase in incidence of respiratory diseases such as chronic obstructive pulmonary disease (COPD) around the world.

Get Sample Copy of This Report@ https://www.qurateresearch.com/report/sample/HnM/QBI-CMR-HnM-55020

End User Outlook and Trend Analysis
Vital signs monitoring devices are usually used in hospitals and clinics, homecare settings, and ambulatory surgical centers. Hospitals and clinics segment held a major share of the vital signs monitoring devices market in 2016 as these devices aid in early detection of deteriorating health condition of patients thus enabling timely medical intervention. Home care settings segment is expected to witness favorable growth during the forecast period due to the increasing preference of patients towards home healthcare considering its convenience and cost effectiveness compared to healthcare institutional settings.

Regional Outlook and Trend Analysis
North America dominated the global vital signs monitoring devices market in 2016 owing to increase in prevalence of chronic diseases, growing awareness regarding cost effectiveness of vital signs monitoring in home care settings and the presence advanced healthcare infrastructure in the region. Asia-Pacific market is expected to witness fastest growth during the forecast period due to the presence of unmet medical needs in the emerging countries and increasing disposable income of the population.

Competitive Analysis
The key players operating in the global vital signs monitoring devices market focus on developing new products and expanding their presence in developing economies. For instance, in March 2015, Welch Allyn, one of the leading medical diagnostic devices company, launched the Welch Allyn Connex Spot Monitor that fully automates capturing of vital signs along with wireless data transfer to an electronic medical records (EMR) system. The single device facilitates monitoring of vital sign parameters such as pulse rate and blood pressure measurement, pulse oximetry for assessing respiratory conditions and fast and accurate measurement of temperature.

Some of the leading players in the global vital signs monitoring devices market are, Welch Allyn (a subsidiary of Hill-Rom Holdings, Inc.), Nonin Medical Inc., Masimo Corporation, SunTech Medical, Inc. (a subsidiary of Halma plc), Medtronic plc, General Electric Company, Nihon Kohden Corporation, A&D Company, Limited, Koninklijke Philips N.V., Contec Medical Systems Co., Ltd. and Smiths Group plc.

Enquiry about Report@ https://www.qurateresearch.com/report/enquiry/HnM/QBI-CMR-HnM-55020

Market Opportunities
Development of technologically advanced vital signs monitoring devices is expected to open new avenues for future growth. With rising inclination of patients and physicians towards using these devices in hospital as well as home care settings, development of cost effective monitoring devices will enable higher adoption of these devices. Moreover, emerging countries form a lucrative market for these devices where related awareness as well as disposable income is on the rise.

Vital Signs Monitoring Devices Market Segmentation:
By Product:
Blood Pressure Monitoring Devices
Blood Pressure Instrument Accessories
Digital BP Monitors
Ambulatory BP Monitors
Aneroid BP Monitors

Pulse Oximeters
Pediatric Pulse Oximeters
Hand-held Pulse Oximeters
Fingertip Pulse Oximeters
Table-top/Bedside Pulse Oximeters
Wrist-worn Pulse Oximeters

Temperature Monitoring Devices
Infrared Thermometers
Temperature Strips
Digital Thermometers

By End User:
Home Care Settings
Hospitals & Clinics
Ambulatory Surgery Centers (ASCs)

Buy This Report@ https://www.qurateresearch.com/report/buy/HnM/QBI-CMR-HnM-55020/

About Us:
Qurate Business Intelligence delivers unique market research solutions to its customers and help them to get equipped with refined information and market insights derived from reports. We are committed to providing best business services and easy processes to get the same. Qurate Business Intelligence considers themselves as strategic partners of their customers and always shows the keen level of interest to deliver quality.

Runwal Platinum,
Ramnagar Colony, Bavdhan,
Pune, Maharashtra, India-411021
https://www.qurateresearch.com/
IN +919881074592
info@qurateresearch.com

This release was published on openPR.